The flashbacks started six months after the assault, and three years of trauma-focused therapy hasn’t stopped them. According to the National Center for PTSD, standard treatments like prolonged exposure and cognitive processing therapy work for many people, but a significant portion continue experiencing debilitating symptoms despite completing evidence-based interventions. Ketamine infusions target the glutamate system and fear memory reconsolidation in ways that may reduce PTSD symptoms when first-line treatments provide insufficient relief.
When Trauma Treatment Doesn’t Work Well Enough
Post-traumatic stress disorder develops when the brain’s threat detection system gets stuck in overdrive after experiencing or witnessing trauma. Your amygdala keeps firing alarm signals even when you’re safe, your hippocampus struggles to properly timestamp traumatic memories as past events, and your prefrontal cortex can’t adequately regulate these fear responses. The result is hypervigilance, intrusive memories, emotional numbing, and avoidance that fundamentally restrict how you live.
Evidence-based trauma therapies like prolonged exposure and EMDR help many people by processing traumatic memories in ways that reduce their emotional charge. Medications like SSRIs can take the edge off symptoms. For many PTSD patients, these approaches provide meaningful improvement or even full remission of symptoms.
But treatment resistance in PTSD is more common than most realize. Some people can’t tolerate the intense emotional activation required for exposure-based therapies. Others complete therapy protocols diligently yet still experience frequent flashbacks, panic attacks, or emotional numbness that makes normal functioning impossible. When you’ve worked with specialized trauma therapists and tried multiple medications without reaching acceptable symptom control, questions arise about what else might help.
The neurobiology of treatment-resistant PTSD involves persistent changes in brain circuits that conventional treatments may not fully address. Research using brain imaging shows that PTSD involves dysfunction in the connections between the amygdala, hippocampus, and prefrontal cortex. These regions need to communicate effectively for you to process threats accurately and respond appropriately. When trauma disrupts this communication, medications that adjust serotonin levels may not be sufficient to restore healthy function.
Research on Ketamine for PTSD
A landmark study published in the American Journal of Psychiatry in 2021 examined ketamine specifically for PTSD treatment. Researchers conducted a randomized, double-blind, placebo-controlled trial giving patients either ketamine or a placebo infusion. The results showed significant PTSD symptom reduction in the ketamine group, with effects sustained at one month after treatment (Feder et al., 2021). This wasn’t just improvement in general anxiety; the measures specifically assessed core PTSD symptoms including intrusive memories, avoidance, and hyperarousal.
Earlier research from 2014 examined ketamine’s rapid effects on PTSD symptoms using a controlled trial design. The study found that within 24 hours of a single ketamine infusion, patients experienced substantial reduction in PTSD severity scores. The rapid response distinguished ketamine from SSRIs, which typically require weeks of daily use before showing benefits (Feder et al., 2014).
A comprehensive review from Yale examined ketamine’s mechanism in trauma-related conditions, focusing on its effects on fear memory and neural plasticity. The research suggests ketamine may help by facilitating fear memory reconsolidation, essentially allowing the brain to update traumatic memories in ways that reduce their emotional intensity (Krystal et al., 2017). This differs from exposure therapy, which works through habituation, suggesting ketamine might complement rather than replace psychological treatments.
The glutamate system plays a central role in learning and memory formation. Traumatic experiences create especially strong memories through processes involving glutamate and NMDA receptors. Ketamine’s blockade of these receptors during the reconsolidation window may help weaken the fear associations attached to traumatic memories without erasing the memories themselves.
Clinical observations suggest that ketamine may be particularly helpful for PTSD symptoms that involve intrusive memories and hyperarousal. Patients often report that flashbacks become less frequent or less vivid, the constant sense of threat diminishes, and sleep improves. Emotional numbing sometimes lessens as well, allowing people to reconnect with feelings they’ve been cut off from since the trauma.
What PTSD Treatment with Ketamine Involves
Treatment at Albany Ketamine Infusions typically follows a protocol of six initial infusions over two to three weeks. Each session lasts approximately one hour, with board-certified anesthesiologist Dr. Philip Hansen monitoring you throughout. You remain conscious during treatment but experience dissociative effects that many trauma survivors find less distressing than anticipated.
The dissociative state during ketamine infusions deserves specific discussion for trauma patients. Many people with PTSD worry that altered consciousness will feel dangerous or trigger traumatic memories. In practice, most patients describe the dissociation as calming rather than frightening. The temporary shift in perception creates distance from your usual thought patterns, including trauma-related rumination that normally dominates your mind.
Some trauma therapists have begun specifically integrating ketamine with trauma processing work. The theory is that ketamine’s effects on fear memory reconsolidation combined with therapeutic processing during the treatment window might enhance outcomes beyond either intervention alone. This approach, sometimes called ketamine-assisted psychotherapy for trauma, involves having a therapist present during or immediately after ketamine sessions to facilitate emotional processing.
Albany Ketamine offers ketamine-assisted psychotherapy as an option for patients interested in this approach. The therapist’s presence during infusions adds cost beyond the ketamine session itself, though the therapist may be covered by your insurance if they’re in-network with your plan. Whether to pursue KAP versus standard ketamine infusions depends on your preferences, financial considerations, and whether you’re currently working with a therapist open to this integration.
Response timing varies among PTSD patients. Some notice reduced hypervigilance and fewer intrusive memories within days of the first infusion. Others experience gradual improvement building over the initial treatment series. Dr. Hansen can typically determine if ketamine is helping after the first two treatments, allowing you to make informed decisions about continuing.
After initial treatment, most patients transition to maintenance infusions as needed. PTSD symptoms may gradually return as ketamine’s direct effects wear off, typically over weeks to months. Booster infusions at that point often restore the symptom relief experienced initially. The average interval is four to six weeks, though your specific needs may differ.
Addressing Concerns Specific to Trauma Survivors
The question of whether dissociation itself might be triggering for trauma survivors is valid. Some people with PTSD have experienced dissociation during or after their trauma, and worry that ketamine-induced dissociation will reactivate those frightening feelings. In practice, the dissociation from therapeutic ketamine feels qualitatively different from trauma-related dissociation for most patients.
Trauma dissociation often involves feeling disconnected in frightening ways, losing time, or experiencing the world as unreal in contexts where you need to feel present and safe. Ketamine dissociation happens in a controlled medical environment where you expect and consent to altered consciousness, typically feels dreamlike rather than terrifying, and resolves completely within minutes after the infusion ends. The control and predictability distinguish therapeutic dissociation from trauma-related experiences.
That said, individual responses vary. If you have concerns about dissociation triggering traumatic memories, discussing this with Dr. Hansen during your consultation helps determine if ketamine is appropriate. Some patients benefit from starting with lower doses to ease into the experience gradually, while others find that having a therapist present during treatment provides enough safety to make the dissociation manageable.
Benzodiazepine use is common among PTSD patients for managing panic attacks or sleep difficulties. Unfortunately, regular benzodiazepine use at higher doses can interfere with ketamine’s effectiveness. This creates a difficult situation: the medications providing some symptom relief might block the benefits of a potentially more effective treatment. Working with your prescribing provider to carefully reduce benzodiazepines before starting ketamine sometimes makes sense, though this decision requires weighing multiple factors about your current stability and support system.
Cost is particularly challenging for trauma survivors, many of whom face employment difficulties due to PTSD symptoms. Each ketamine infusion costs $395, with the initial series running approximately $2,370. Some insurance companies provide partial reimbursement for out-of-network mental health treatment, and about 30-35% of Albany Ketamine patients see some insurance coverage. Financing through Advance Care offers payment plans for patients who need them.
Veterans with service-related PTSD should inquire about special fee considerations. Albany Ketamine recognizes the particular challenges veterans face and works to reduce financial barriers when possible. While the clinic can’t guarantee reduced fees for all veterans, they encourage military members to discuss their situation during the consultation.
Combining Ketamine with Trauma Therapy
Ketamine appears most effective when integrated with ongoing psychological treatment rather than used in isolation. If ketamine reduces the intensity of your hyperarousal and intrusive memories, that symptom relief creates an opportunity for more productive therapy work. The fear and avoidance that previously made trauma processing unbearable may become more manageable when ketamine lowers your baseline distress.
Some trauma therapists time therapy sessions for the days and weeks when ketamine effects are strongest. If you’re less reactive to trauma reminders during this window, you might finally be able to engage with exposure exercises or memory processing work that felt impossible before. The skills and insights developed during periods of reduced symptoms may persist even as ketamine’s direct effects eventually fade.
This doesn’t mean ketamine replaces trauma therapy. Most trauma specialists consider ketamine a potential augmentation strategy rather than a standalone treatment. The research showing ketamine’s effects on fear memory suggests it could make therapy more efficient, but doesn’t indicate that ketamine alone will resolve complex trauma without psychological processing.
Your existing therapeutic relationships matter when considering ketamine. If you’ve built trust with a trauma therapist over months or years, maintaining that relationship while adding ketamine makes sense. Some trauma therapists are open to coordinating with ketamine providers, attending ketamine sessions, or adjusting therapy timing to maximize the benefits of both approaches.
Who Should Consider Ketamine for PTSD
Ketamine isn’t first-line treatment for newly diagnosed PTSD. If you haven’t tried evidence-based trauma therapies like prolonged exposure, cognitive processing therapy, or EMDR, those should come first. The research supporting these approaches is extensive, and many people achieve remission or significant improvement with specialized trauma therapy alone.
Treatment resistance provides the context where ketamine makes sense. If you’ve completed trauma-focused therapy with a qualified provider, tried at least two SSRIs or SNRIs at adequate doses, and your PTSD symptoms still significantly impair functioning, you meet reasonable criteria for considering ketamine. Some trauma survivors have tried multiple therapy approaches, participated in intensive treatment programs, and added prazosin for nightmares without reaching acceptable symptom control. Ketamine offers these patients another option.
The severity and type of PTSD symptoms may influence response to ketamine, though research hasn’t definitively identified which presentations benefit most. Whether your PTSD involves primarily intrusive memories, severe hyperarousal, emotional numbing, or dissociative symptoms, ketamine targets underlying fear circuits rather than specific symptom presentations. Clinical experience suggests patients with prominent hyperarousal and re-experiencing symptoms often show good responses.
Medical conditions rarely exclude PTSD patients from ketamine treatment. Uncontrolled hypertension or significant cardiac problems would need stabilization first, but most health issues don’t prevent treatment. The free phone consultation with Albany Ketamine’s administrative staff helps identify any concerns requiring attention before starting infusions. Initial consultations can also be conducted via secure telemedicine, allowing you to meet with Dr. Hansen remotely to discuss your trauma history and treatment options from the comfort of your home.
Life After Ketamine Treatment for Trauma
Ketamine may reduce PTSD symptoms substantially, but it doesn’t cure trauma or erase traumatic memories. The condition’s chronic nature means ongoing management typically remains necessary. Some trauma survivors find that ketamine creates enough symptom relief for them to finally engage effectively with trauma therapy and develop healthier coping strategies. The skills built during periods of reduced symptoms may carry forward even when ketamine effects diminish.
Maintenance infusions help sustain benefits over time. Most patients find PTSD symptoms gradually return as weeks pass after treatment. A booster infusion at that point often restores the relief experienced during initial treatment. The timing of boosters varies based on when you notice symptoms intensifying, with most patients averaging four to six weeks between treatments.
The relationship between PTSD and depression matters for long-term outcomes. Many trauma survivors experience both conditions simultaneously, and ketamine’s antidepressant effects may help both presentations. Improved mood can increase your capacity to engage in trauma recovery work and rebuild your life after trauma.
Coordinating care across providers optimizes outcomes. Your trauma therapist, prescribing psychiatrist or primary care provider, and ketamine physician should ideally communicate about your treatment plan. Albany Ketamine can provide treatment even if this coordination isn’t possible, but shared information among providers generally leads to better results.
Albany’s Approach to Trauma Treatment
The Capital Region has limited providers offering ketamine specifically for PTSD. Albany Ketamine Infusions‘ exclusive focus on ketamine therapy means Dr. Philip Hansen has extensive experience treating trauma survivors and understands the specific concerns they face. This specialization differs from general psychiatric practices that offer ketamine as one service among many.
The clinic operates seven days a week including weekends, recognizing that PTSD symptoms don’t respect traditional business hours. Fifteen private treatment rooms ensure you won’t share space during infusions, providing the privacy and quiet that many trauma survivors need to feel safe during treatment.
Dr. Hansen’s training under Dr. Glen Brooks at NY Ketamine Infusions provided specialized mentorship in psychiatric applications of ketamine beyond general anesthesiology training. This focused experience with mental health conditions helps in understanding how PTSD specifically responds to treatment and what adjustments might optimize individual outcomes.
The option for ketamine-assisted psychotherapy allows trauma survivors interested in this approach to have a therapist present during infusions. This integration of ketamine with trauma processing work represents a specialized application that requires coordination between medical and therapeutic providers.
FAQ
Q: Will ketamine make me relive my trauma during the infusion?
A: Most PTSD patients don’t experience traumatic flashbacks during ketamine infusions. The dissociative effects typically feel dreamlike or introspective rather than triggering. Some patients report that ketamine actually provides temporary relief from intrusive memories during treatment. If you have specific concerns about trauma activation, discuss them during your consultation.
Q: How quickly does ketamine help PTSD symptoms?
A: Research shows significant symptom reduction can occur within 24 hours of a single infusion, with many patients noticing reduced hypervigilance, fewer intrusive memories, or better sleep within days. Others experience gradual improvement over the initial six-treatment series. Individual response varies, but ketamine’s rapid action means you’ll know relatively quickly whether it’s helping.
Q: Can I continue my PTSD medications during ketamine treatment?
A: SSRIs, SNRIs, and prazosin are safe to continue and won’t interfere with ketamine. However, benzodiazepines taken daily at higher doses can reduce ketamine’s effectiveness. Your consultation will address your specific medications and whether adjustments might optimize treatment outcomes. Never stop psychiatric medications without guidance from your prescribing provider.
Q: Do I need to be in therapy to receive ketamine treatment for PTSD?
A: You don’t need to be currently in therapy to receive ketamine infusions, though many trauma specialists believe ketamine works best when combined with psychological treatment. If you’re not currently working with a therapist, ketamine may still help reduce symptoms. However, consider connecting with a trauma-specialized therapist to maximize benefits and address underlying trauma beyond symptom management.
Q: What if ketamine only partially helps my PTSD?
A: Partial symptom reduction can still significantly improve quality of life. If ketamine reduces hyperarousal from severe to moderate, that might mean you can finally sleep through the night, hold employment, or engage in relationships. Complete symptom elimination is rare with any PTSD treatment; the goal is achieving the best possible functioning and quality of life.
Conclusion
Treatment-resistant PTSD profoundly impacts daily functioning, relationships, and overall quality of life. Ketamine infusions target fear memory circuits and neural plasticity in ways that may reduce symptoms when evidence-based trauma therapies and medications provide insufficient relief. Research demonstrates rapid symptom improvement in controlled trials, and clinical experience shows real-world effectiveness for many trauma survivors.
Understanding what treatment involves helps you make informed decisions: the time commitment, costs, what the dissociative experience entails, and realistic expectations about symptom reduction. Results vary by individual, and ketamine won’t work for everyone with PTSD. But for trauma survivors whose symptoms persist despite completing trauma-focused therapy and trying multiple medications, it represents a research-backed option worth considering.
If you’re ready to explore ketamine treatment for PTSD, Albany Ketamine Infusions offers specialized care from board-certified anesthesiologists experienced in treating trauma-related conditions. Call 518-249-5700 for a free phone consultation to discuss your trauma history, treatment attempts, and whether ketamine infusions could help your symptoms.
References
Feder, A., Costi, S., Rutter, S. B., Collins, A. B., Govindarajulu, U., Jha, M. K., Horn, S. R., Kautz, M., Corniquel, M., Collins, K. A., Bevilacqua, L., Glasgow, A. M., Brallier, J., Pietrzak, R. H., Murrough, J. W., & Charney, D. S. (2021). A randomized controlled trial of repeated ketamine administration for chronic posttraumatic stress disorder. American Journal of Psychiatry, 178(2), 193-202. https://doi.org/10.1176/appi.ajp.2020.20050596
Feder, A., Parides, M. K., Murrough, J. W., Perez, A. M., Morgan, J. E., Saxena, S., Kirkwood, K., Aan Het Rot, M., Lapidus, K. A., Wan, L. B., Iosifescu, D., & Charney, D. S. (2014). Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: A randomized clinical trial. JAMA Psychiatry, 71(6), 681-688. https://doi.org/10.1001/jamapsychiatry.2014.62
Krystal, J. H., Abdallah, C. G., Sanacora, G., Charney, D. S., & Duman, R. S. (2017). Ketamine: A paradigm shift for depression research and treatment. Neuron, 101(5), 774-778. https://doi.org/10.1016/j.neuron.2019.02.005
National Center for PTSD, U.S. Department of Veterans Affairs. (2024). PTSD: National Center for PTSD – Treatment overview. https://www.ptsd.va.gov/understand_tx/index.asp